Home Induction of Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy

Obstet Gynecol. 2021 Oct 1;138(4):655-659. doi: 10.1097/AOG.0000000000004539.

Authors

Jeannie C Kelly¹, Nandini Raghuraman, Molly J Stout, Sharman Russell, Marta Perez, Sarah Nazeer, Nicole El Helou, Fan Zhang, Ebony Carter

Affiliation

¹ Division of Maternal Fetal Medicine and the Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, Missouri; and the Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.

PMID: 34623078
DOI: 10.1097/AOG.0000000000004539

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Buprenorphine / therapeutic use*
Female
Humans
Narcotic Antagonists / therapeutic use*
Opiate Substitution Treatment / methods
Opioid-Related Disorders / drug therapy*
Pregnancy
Pregnancy Complications / drug therapy*
Retrospective Studies
Substance Withdrawal Syndrome / epidemiology
Treatment Outcome

Substances

Narcotic Antagonists
Buprenorphine